Ms. Carin Fradin serves as a member of TransMed7’s Business Advisory Board.
Ms. Fradin is Managing Director of Investment Banking in JMP Securities and based in the firm’s San Francisco office. Ms. Fradin is expected to bolster JMP Securities’ investment banking efforts in the medical device sector. She has an impressive background in mergers and acquisitions. She is remarkably well recognized in the healthcare arena for her unique knowledge and experience in the equity related activities in the medical device and supplies sector.
Prior to joining JMP Securities, Ms. Fradin was a Managing Director at Four Oaks Partners, a transaction advisory firm serving the life sciences industry, where she focused on the medical device space. Prior to this she was a Managing Director and Senior Advisor at investment bank Sagent Advisors. In addition, Ms. Fradin also spent 12 years in healthcare investment banking at UBS Investment Bank, most recently as a Managing Director, concentrating on the medical device and medical technology industries. Prior to that at UBS she led the U.S. execution of all cross-border medical technology transactions originated in Asia. Ms. Fradin has worked with and represented companies around the world at all stages of development, from private, pre-revenue companies to multi-billion dollar public companies.
Ms. Fradin holds a BA in mathematics and psychology from the University of Pennsylvania.